Day Return
YTD Return
1-Year Return
3-Year Return
5-Year Return
Note: Sector performance is calculated based on the previous closing price of all sector constituents
Industries in This Sector
Select an Industry for a Visual Breakdown
| Industry | Market Weight | YTD Return | |
|---|---|---|---|
| All Industries | 100.00% | 6.55% | |
| Drug Manufacturers - General | 33.37% | 4.21% | |
| Medical Devices | 13.58% | 10.75% | |
| Healthcare Plans | 12.50% | 9.33% | |
| Biotechnology | 10.91% | 4.85% | |
| Diagnostics & Research | 10.84% | 4.15% | |
| Medical Instruments & Supplies | 8.08% | 7.25% | |
| Medical Care Facilities | 3.00% | 11.18% | |
| Drug Manufacturers - Specialty & Generic | 2.65% | 5.10% | |
| Medical Distribution | 2.53% | 7.79% | |
| Health Information Services | 2.43% | 14.96% | |
| Pharmaceutical Retailers | 0.13% | 5.48% | |
Note: Percentage % data on heatmap indicates Day Return
All Industries
--
<= -3
-2
-1
0
1
2
>= 3
Largest Companies in This Sector
View MoreName | Last Price | 1Y Target Est. | Market Weight | Market Cap | Day Change % | YTD Return | Avg. Analyst Rating |
|---|---|---|---|---|---|---|---|
| | 972.57 | 11.23% | | | | Buy | |
| | 637.24 | 7.59% | | | | Strong Buy | |
| | 168.64 | 5.59% | | | | Buy | |
| | 204.90 | 5.07% | | | | Buy | |
| | 123.63 | 3.47% | | | | Buy | |
| | 133.08 | 3.39% | | | | Buy | |
| | 662.36 | 3.36% | | | | Buy | |
| | 629.37 | 3.12% | | | | Buy | |
| | 315.85 | 2.35% | | | | Buy | |
| | 268.88 | 2.35% | | | | Buy |
Investing in the Healthcare Sector
Start Investing in the Healthcare Sector Through These ETFs and Mutual Funds
ETF Opportunities
View MoreName | Last Price | Net Assets | Expense Ratio | YTD Return |
|---|---|---|---|---|
| | 36.396B | 0.09% | | |
| | 18.975B | 0.10% | | |
| | 6.463B | 0.45% | | |
| | 6.369B | 0.35% | | |
| | 4.4B | 0.40% | |
Mutual Fund Opportunities
View MoreName | Last Price | Net Assets | Expense Ratio | YTD Return |
|---|---|---|---|---|
| | 40.511B | 0.30% | | |
| | 40.511B | 0.30% | | |
| | 18.975B | 0.10% | | |
| | 13.014B | 0.80% | | |
| | 13.014B | 0.80% | |
Healthcare Research
View MoreDiscover the Latest Analyst and Technical Research for This Sector
Analyst Report: Danaher Corp.
Danaher is a diversified life sciences and diagnostics company with global operations. Its products and solutions support the biopharma industry in the development and production of therapies. Its Diagnostics segment provides clinical instruments, reagents, and consumables to hospitals, physicians' offices, and reference laboratories. In March 2020, it acquired the GE Biopharma business and renamed it Cytiva. Danaher has continued to make acquisitions, including Aldevron in 2021 and Abcam in 2023. These acquisitions broaden its technology offerings and expand manufacturing capabilities.
RatingPrice TargetMarket Digest: NLY, CHD, DHR, EL, VIAV, LMT, XRX, XYL, PYPL
The stock market got back to its winning ways on Tuesday as the tariff scare faded. That means DeepSeek AI must be really old news. In a bull market, stocks often deal with difficult news and then move higher. The advance was fairly broad, with the S&P 500 (SPX) rising 0.7%, the S&P 100 up 0.9%, and the Nasdaq and Nasdaq 100 tacking on 1.3%. The S&P MidCap 400 added 0.6%, while the S&P SmallCap 600 jumped 1.2%. Turning to sectors, it was a minor risk-on day, with Energy, Information Technology, Consumer Discretionary, and Communication Services rising between 0.9% and 2%, Utilities, Consumer Staples, Financial, and Healthcare were down 0.3% to 0.9%. One of our recent themes has been a break in the U.S. Dollar (USD) and bullish implications for emerging markets. USD topped on January 13 and broke its uptrend on January 21, with the initial pullback falling from $110 to $106.80. The greenback snapped back to $109.75 on February 3, but failed right at former trendline support. USD closed at $108 on Tuesday and appears to be tracing out a double top. The dollar peak coincided with a peak in Treasury yields across the curve. The Commitment of Traders (COT) data was a big reason we were cautious on the greenback. The iShares Emerging Markets (EEM) bottomed on January 13 and broke its downtrend off the October 7 peak. We have seen a five-day/13-day exponential moving average (EMA) crossover buy signal and a completed small inverse head-and-shoulders formation. Emerging markets are highly, negatively correlated with USD. The iShares China Large-Cap (FXI) bottomed On January 10 and a break over $33.25 will complete a small base. It would be nice if some other global markets came to life.
Daily – Vickers Top Insider Picks for 02/05/2025
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Buyers & Sellers for 02/05/2025
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.





















